Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 69 Records) |
| Query Trace: Neoplasms and TMPRSS2[original query] |
|---|
| Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer. Oncotarget 2020 Apr 11 (15): 1321-1333. Kohaar Indu, Li Qiyuan, Chen Yongmei, Ravindranath Lakshmi, Young Denise, Ali Amina, Sesterhenn Isabell A, Rosner Inger L, Cullen Jennifer, Srivastava Shiv, Freedman Matthew, Petrovics Gyor |
| The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer. The Journal of clinical investigation 2020 4 130 (8): 3987-4005. Ramanand Susmita G, Chen Yong, Yuan Jiapei, Daescu Kelly, Lambros Maryou Bk, Houlahan Kathleen E, Carreira Suzanne, Yuan Wei, Baek GuemHee, Sharp Adam, Paschalis Alec, Kanchwala Mohammed, Gao Yunpeng, Aslam Adam, Safdar Nida, Zhan Xiaowei, Raj Ganesh V, Xing Chao, Boutros Paul C, de Bono Johann, Zhang Michael Q, Mani Ram |
| Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer. Frontiers in genetics 2020 12 11 595657. Zhang Enchong, He Jieqian, Zhang Hui, Shan Liping, Wu Hongliang, Zhang Mo, Song Yongshe |
| Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy. Genes 2020 12 12 (1): . Zarubin Aleksei, Stepanov Vadim, Markov Anton, Kolesnikov Nikita, Marusin Andrey, Khitrinskaya Irina, Swarovskaya Maria, Litvinov Sergey, Ekomasova Natalia, Dzhaubermezov Murat, Maksimova Nadezhda, Sukhomyasova Aitalina, Shtygasheva Olga, Khusnutdinova Elza, Radzhabov Magomed, Kharkov Vladim |
| Distinct Genomic Alterations in Prostate Tumors Derived from African American Men. Molecular cancer research : MCR 2020 10 18 (12): 1815-1824. Liu Wennuan, Zheng S Lilly, Na Rong, Wei Lin, Sun Jishan, Gallagher Johnie, Wei Jun, Resurreccion W Kyle, Ernst Sarah, Sfanos Karen S, Isaacs William B, Xu Jianfe |
| NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer. FEBS open bio 2020 Oct . Tang Lu, Zhang Lixia, Liu Lei, Dong Liping, Dong Yuan, Zhu Wenhe, Wang Huiy |
| Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators. Frontiers in medicine 2021 8 8 662460. Zhang Jian, Jiang Huali, Du Kunpeng, Xie Tao, Wang Baiyao, Chen Chengcong, Cen Bohong, Yuan Yawei, Ye Jiac |
| Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation. International journal of biological sciences 2021 6 17 (8): 1925-1939. Tang Qian, Wang Yue, Ou Ling, Li Jieling, Zheng Kai, Zhan Hui, Gu Jiayu, Zhou Guibao, Xie Shouxia, Zhang Jianping, Huang Wei, Wang Shaoxiang, Wang Xi |
| Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance. Investigative and clinical urology 2021 Mar 62 (2): 224-232. Yu Jiwoong, Cho Eunhae, Choi Joongwon, Lim Joung Eun, Lee Junnam, Kang Minyong, Sung Hyun Hwan, Jeong Byong Chang, Seo Seong Il, Jeon Seong Soo, Lee Hyun Moo, Jeon Hwang Gy |
| Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer. European journal of cancer (Oxford, England : 1990) 2021 2 147 74-83. Lozano Rebeca, Salles Daniela C, Sandhu Shahneen, Aragón Isabel M, Thorne Heather, López-Campos Fernando, Rubio-Briones José, Gutierrez-Pecharroman Ana M, Maldonado Laneisha, di Domenico Tomas, Sanz Alejandro, Prieto Juan D, García Isabel, Pacheco María I, Garcés Teresa, Llacer Casilda, Romero-Laorden Nuria, Zambrana Francisco, López-Casas Pedro P, Lorente David, Mateo Joaquin, Pritchard Colin C, Antonarakis Emmanuel S, Olmos David, Lotan Tamara L, Castro Ele |
| Clinical and genomic features of SPOP-mutant prostate cancer. The Prostate 2021 Nov . Nakazawa Mari, Fang Mike, H Marshall Catherine, Lotan Tamara L, Isaacsson Velho Pedro, Antonarakis Emmanuel |
| Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions. Prostate cancer and prostatic diseases 2021 Jan . Chalmers Zachary R, Burns Michael C, Ebot Ericka M, Frampton Garrett M, Ross Jeffrey S, Hussain Maha H A, Abdulkadir Sarki |
| Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer. Frontiers in oncology 2022 12 957404. Zhou Jie, Lai Yiming, Peng Shengmeng, Tang Chen, Chen Yongming, Li Lingfeng, Huang Hai, Guo Zhengh |
| Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers. Genome medicine 2022 Aug 14 (1): 100. Gong Tingting, Jaratlerdsiri Weerachai, Jiang Jue, Willet Cali, Chew Tracy, Patrick Sean M, Lyons Ruth J, Haynes Anne-Maree, Pasqualim Gabriela, Brum Ilma Simoni, Stricker Phillip D, Mutambirwa Shingai B A, Sadsad Rosemarie, Papenfuss Anthony T, Bornman Riana M S, Chan Eva K F, Hayes Vanessa |
| The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. The Prostate 2022 Jun . Liu Alex J, Kosiorek Heidi E, Ueberroth Benjamin E, Jaeger Ellen, Ledet Elisa, Kendi Ayse T, Tzou Katherine, Quevedo Fernando, Choo Richard, Moore Cassandra N, Ho Thai H, Singh Parminder, Keole Sameer R, Wong William W, Sartor Oliver, Bryce Alan |
| The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer. NPJ precision oncology 2022 Jun 6 (1): 39. Kensler Kevin H, Baichoo Shakuntala, Pathania Shailja, Rebbeck Timothy |
| Evaluation of NOTCH family genes' expression and prognostic value in prostate cancer. Translational andrology and urology 2022 6 11 (5): 627-642. Qing Yunhao, Wang Yu, Hu Cheng, Zhang Huimin, Huang Ye'an, Zhang Zixiao, Ma Tan, Zhang Shuoqi, Li |
| Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG. Nature communications 2022 11 13 (1): 7320. Giannareas Nikolaos, Zhang Qin, Yang Xiayun, Na Rong, Tian Yijun, Yang Yuehong, Ruan Xiaohao, Huang Da, Yang Xiaoqun, Wang Chaofu, Zhang Peng, Manninen Aki, Wang Liang, Wei Gong-Ho |
| Determination of ERG(+), EZH2, NKX3.1, and SPINK-1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer. Cancer reports (Hoboken, N.J.) 2022 10 e1728. Segura-Moreno Yenifer Yamile, Sanabria-Salas María Carolina, Mesa-López De Mesa Jorge Andrés, Varela-Ramirez Rodolfo, Acosta-Vega Natalia Lizeth, Serrano Martha Luc |
| Germline genetic variants associated with somatic TMPRSS2:ERG fusion status in prostate cancer: a genome-wide association study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 8 . Chaoran Ma, Xiaoyu Wang, James Y Dai, Constance Turman, Peter Kraft, Konrad H Stopsack, Massimo Loda, Andreas Pettersson, Lorelei A Mucci, Janet L Stanford, Kathryn L Penn |
| Unique spectrum of activating BRAF alterations in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 7 . Alex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, Smruthy Sivakumar, Alexa B Schrock, Hannah E Bergom, Hedyeh Ebrahimi, Sumanta Pal, Tanya Dorff, Neeraj Agarwal, Brandon A Mahal, Geoffrey R Oxnard, Justin Hwang, Emmanuel S Antonarak |
| Prostate cancer genetic alterations in Hispanic men. The Prostate 2023 6 . Camilo Arenas-Gallo, Stephen Rhodes, Jorge A Garcia, Ilon Weinstein, Megan Prunty, Patrick Lewicki, Aaron Brant, Spyridon P Basourakos, Christopher E Barbieri, Noa Lifschutz, Fredrick R Schumacher, Jonathan E Sho |
| A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk. International journal of molecular sciences 2023 4 24 (8): . Maria Antonietta Manca, Fabio Scarpa, Davide Cossu, Elena Rita Simula, Daria Sanna, Stefano Ruberto, Marta Noli, Hajra Ashraf, Tatiana Solinas, Massimo Madonia, Roberto Cusano, Leonardo A Sec |
| Determination of TMPRSS2-ERG, SPOP, FOXA1, and IDH1 prostate cancer molecular subtypes in Colombian patients and their possible implications for prognosis. Cell biology international 2023 2 . Montero-Ovalle Wendy, Sanabria-Salas María C, Mesa-López de Mesa Jorge, Varela-Ramírez Rodolfo, Segura-Moreno Yenifer Y, Sánchez-Villalobos Santiago A, Nuñez-Lemus Marcela, Serrano Martha |
| Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJ. The Prostate 2023 10 . Raphaela Dos Santos Menezes, Maria Cristina Dornas, Carlos Frederico Ferreira Campos, Daniela Bouzas Rodeiro, Fabricio Borges Carrerette, Romulo Vianna Oliveira, Brenda Amaral de Souza, Gabriele Alves de Souza Carvalho, Ingrid Alexandre de Abreu Brito, Dayse Aparecida Silva, Ronaldo Damião, Luís Cristóvão Por |
| Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis. Urologic oncology 2023 10 . Mohammed Al-Toubat, Samuel Serrano, Ahmed Elshafei, Kashyap Koul, Allison H Feibus, K C Bala |
| The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer. Journal of clinical medicine 2023 1 12 (2): . Fang Bangwei, Wei Yu, Pan Jian, Zhang Tingwei, Ye Dingwei, Zhu Y |
| TMPRSS2:ERG Gene Fusion Might Predict Resistance to PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer. Anticancer research 2024 9 44 (10): 4203-4211. Tim Svenstrup Poulsen, Anders Nygaard Lørup, Per Kongsted, Rikke Løvendahl Eefsen, Martin Højgaard, Estrid Vilma Høgda |
| PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer. The Prostate 2024 7 . Philip Sutera, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, Saum Ghodoussipour, Thomas Jang, David Golombos, Vignesh Packiam, Ronald Ennis, Lara Hathout, Salma K Jabbour, Ozan Guler, Cem Onal, Phuoc T Tran, Matthew P De |
| Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer. Frontiers in oncology 2024 4 14 1381134. Michael C Repka, Tamir Sholklapper, Alan L Zwart, Malika Danner, Marilyn Ayoob, Thomas Yung, Siyuan Lei, Brian T Collins, Deepak Kumar, Simeng Suy, Ryan A Hankins, Amar U Kishan, Sean P Colli |
- Page last reviewed:Feb 1, 2024
- Content source: